Boston Scientific Corporation · NYSE:BSX

Boston Scientific — Technical Presentation (2023)

31 slides from Boston Scientific's technical presentation, 2023

  1. Slide 1: Economic Impact of TAVI related Stroke

    Economic Impact of TAVI related Stroke Disabling Stroke Cost Analysis with and without Cerebral Embolic Protection

  2. Slide 2: Socio-economic impact of stroke

    Socio-economic impact of stroke TAVI-related stroke apart from its devastating clinical impact would also add a considerable economic burden to healthcare systems, patients & society Health and social care costs Non-healthcare costs HOSPITAL CARE 28% 10% PRODUCTIVITY LOSS • Stroke Unit/ DUE TO DISAB

  3. Slide 3: Impact from short to long term

    Impact from short to long term Significant Increase in Acute and Long-Term Disabling Stroke Costs Short-term costs Mid to long-term costs HOSPITALISATION DISCHARGE 3 MONTHS 6 MONTHS 12 MONTHS ACUTE SEVERE ISCHEMIC SOCIAL AND ECONOMIC STROKE MANAGEMENT COST COSTS PER PATIENT** in Western Europe 1 in

  4. Slide 4: Benefits of CEP can be considerable

    Benefits of CEP can be considerable For EU Big5 in 2021 MORE THAN 66 K ~900 DISABLING STROKES WITHOUT CEP TAVI PROCEDURES DISABLING DISABLING STROKES Performed in EU Big5 ~6,700 STROKES AFTER TAVI WITH CEP in 2021 ~90 TAVI ~26,800 ~36 ~360 TAVI Without CEP ~143 ~16,900 €30 M ~230 TAVI ~10,000 +500 O

  5. Slide 5: Costs of Disabling Stroke after TAVI

    Costs of Disabling Stroke after TAVI Benefits of TAVI with CEP in EU Big 5 SELECT THE COUNTRY FLAGS TO LEARN MORE ABOUT THE DISABLING STROKE COSTS TAVI without CEP vs. TAVI with CEP © 2023 Boston Scientific Corporation or its affiliates. All right reserved. SH-1586805-AA

  6. Slide 6: Benefits of CEP in France

    Benefits of CEP in France © 2023 Boston Scientific Corporation or its affiliates. All right reserved. SH-1586805-AA

  7. Slide 7: Burden of Stroke in France

    Burden of Stroke in France In France, the Economic Burden of stroke is Significant for the Healthcare system, Patients and Society. Health and social care costs Non-healthcare costs HOSPITAL CARE 21% 9% PRODUCTIVITY LOSS • Stroke Unit/ DUE TO DISABILITY Neurology • Work absence • Length of Stay • Di

  8. Slide 8: Impact from short to long term

    Impact from short to long term Significant Increase in Acute and Long-Term Disabling Stroke Costs Short-term costs Mid to long-term costs HOSPITALISATION DISCHARGE 3 MONTHS 6 MONTHS 12 MONTHS ACUTE SEVERE ISCHEMIC SOCIAL AND ECONOMIC STROKE MANAGEMENT COST COSTS PER PATIENT** 1 1 ,2 in France in the

  9. Slide 9: Clinical Benefits of SENTINEL CPS

    Clinical Benefits of SENTINEL CPS ~16,900 TAVI PATIENTS In France in 2021 What happens in patients receiving What happens in patients receiving TAVI without CEP? TAVI with CEP? DISABLING STROKE DISABLING STROKE What are the NON-DISABLING STROKE What are the NON-DISABLING STROKE clinical outcomes? cl

  10. Slide 10: Economic Benefits of SENTINEL CPS

    Economic Benefits of SENTINEL CPS ~16,900 TAVI PATIENTS In France in 2021 What happens in patients receiving What happens in patients receiving TAVI without CEP? TAVI with CEP? What are the clinical outcomes? ~ 230 - 140 What is the DISABLING STROKES DISABLING STROKES AVOIDED What are economic impac

  11. Slide 11: Benefits of CEP in Germany

    Benefits of CEP in Germany © 2023 Boston Scientific Corporation or its affiliates. All right reserved. SH-1586805-AA

  12. Slide 12: Burden of Stroke in Germany

    Burden of Stroke in Germany In Germany, the Economic Burden of stroke is Significant for the Healthcare system, Patients and Society. Health and social care costs Non-healthcare costs HOSPITAL CARE 37% 8% PRODUCTIVITY LOSS • Stroke Unit/ DUE TO DEATH Neurology • Work loss due to • Length of Stay ear

  13. Slide 13: Impact from short to long term

    Impact from short to long term Significant Increase in Acute and Long-Term Disabling Stroke Costs Short-term costs Mid to long-term costs HOSPITALISATION DISCHARGE 3 MONTHS 6 MONTHS 12 MONTHS ACUTE SEVERE ISCHEMIC SOCIAL AND ECONOMIC STROKE MANAGEMENT COST COSTS PER PATIENT** 1 1-3 in Germany in the

  14. Slide 14: Clinical Benefits of SENTINEL CPS

    Clinical Benefits of SENTINEL CPS ~26,800 TAVI PATIENTS In Germany in 2021 What happens in patients receiving What happens in patients receiving TAVI without CEP? TAVI with CEP? DISABLING STROKE DISABLING STROKE What are the NON-DISABLING STROKE What are the NON-DISABLING STROKE clinical outcomes? c

  15. Slide 15: Economic Benefits of SENTINEL CPS

    Economic Benefits of SENTINEL CPS ~26,800 TAVI PATIENTS In Germany in 2021 What happens in patients receiving What happens in patients receiving TAVI without CEP? TAVI with CEP? What are the clinical outcomes? ~ 360 - 217 What is the DISABLING STROKES DISABLING STROKES AVOIDED What are economic impa

  16. Slide 16: Benefits of CEP in Italy

    Benefits of CEP in Italy © 2023 Boston Scientific Corporation or its affiliates. All right reserved. SH-1586805-AA

  17. Slide 17: Burden of Stroke in Italy

    Burden of Stroke in Italy In Italy, the Economic Burden of stroke is Significant for the Healthcare system, Patients and Society. Health and social care costs Non-healthcare costs HOSPITAL CARE 32% 7% PRODUCTIVITY LOSS • Stroke Unit/ DUE TO DISABILITY Neurology • Work absence • Length of Stay • Disa

  18. Slide 18: Impact from short to long term

    Impact from short to long term Significant Increase in Acute and Long-Term Disabling Stroke Costs Short-term costs Mid to long-term costs HOSPITALISATION DISCHARGE 3 MONTHS 6 MONTHS 12 MONTHS ACUTE SEVERE ISCHEMIC SOCIAL AND ECONOMIC STROKE MANAGEMENT COST COSTS PER PATIENT** in Italy 1 1 in the fir

  19. Slide 19: Clinical Benefits of SENTINEL CPS

    Clinical Benefits of SENTINEL CPS ~10,000 TAVI PATIENTS in Italy in 2021 What happens in patients receiving What happens in patients receiving TAVI without CEP? TAVI with CEP? DISABLING STROKE DISABLING STROKE What are the NON-DISABLING STROKE What are the NON-DISABLING STROKE clinical outcomes? cli

  20. Slide 20: Economic Benefits of SENTINEL CPS

    Economic Benefits of SENTINEL CPS ~10,000 TAVI PATIENTS in Italy in 2021 What happens in patients receiving What happens in patients receiving TAVI without CEP? TAVI with CEP? What are the clinical outcomes? ~ 140 - 86 What is the DISABLING STROKES DISABLING STROKES AVOIDED What are economic impact?

  21. Slide 21: Benefits of CEP in Spain

    Benefits of CEP in Spain © 2023 Boston Scientific Corporation or its affiliates. All right reserved. SH-1586805-AA

  22. Slide 22: Burden of Stroke in Spain

    Burden of Stroke in Spain In Spain, the Economic Burden of stroke is Significant for the Healthcare system, Patients and Society. Health and social care costs Non-healthcare costs HOSPITAL CARE 17% 11% PRODUCTIVITY LOSS • Stroke Unit/ DUE TO DISABILITY Neurology • Work absence • Length of Stay • Dis

  23. Slide 23: Impact from short to long term

    Impact from short to long term Significant Increase in Acute and Long-Term Disabling Stroke Costs Short-term costs Mid to long-term costs HOSPITALISATION DISCHARGE 3 MONTHS 6 MONTHS 12 MONTHS ACUTE SEVERE ISCHEMIC SOCIAL AND ECONOMIC STROKE MANAGEMENT COST COSTS PER PATIENT** 1 1-3 in Spain in the f

  24. Slide 24: Clinical Benefits of SENTINEL CPS

    Clinical Benefits of SENTINEL CPS ~5,700 TAVI PATIENTS in Spain in 2021 What happens in patients receiving What happens in patients receiving TAVI without CEP? TAVI with CEP? DISABLING STROKE DISABLING STROKE What are the NON-DISABLING STROKE What are the NON-DISABLING STROKE clinical outcomes? clin

  25. Slide 25: Economic Benefits of SENTINEL CPS

    Economic Benefits of SENTINEL CPS ~5,700 TAVI PATIENTS in Spain in 2021 What happens in patients receiving What happens in patients receiving TAVI without CEP? TAVI with CEP? What are the clinical outcomes? ~ 80 - 50 What is the DISABLING STROKES DISABLING STROKES AVOIDED What are economic impact? a

  26. Slide 26: Benefits of CEP in the UK

    Benefits of CEP in the UK © 2023 Boston Scientific Corporation or its affiliates. All right reserved. SH-1586805-AA

  27. Slide 27: Burden of Stroke in the UK

    Burden of Stroke in the UK In the UK, the Economic Burden of stroke is Significant for the Healthcare system, Patients and Society. Health and social care costs Non-healthcare costs HOSPITAL CARE 22% 14% PRODUCTIVITY LOSS • Stroke Unit/ DUE TO DISABILITY Neurology • Work absence • Length of Stay • D

  28. Slide 28: Impact from short to long term

    Impact from short to long term Significant Increase in Acute and Long-Term Disabling Stroke Costs Short-term costs Mid to long-term costs HOSPITALISATION DISCHARGE 3 MONTHS 6 MONTHS 12 MONTHS ACUTE SEVERE ISCHEMIC SOCIAL AND ECONOMIC STROKE MANAGEMENT COST COSTS PER PATIENT** 1 2 in the UK in the fi

  29. Slide 29: Clinical Benefits of SENTINEL CPS

    Clinical Benefits of SENTINEL CPS ~6,700 TAVI PATIENTS In the UK in 2021 What happens in patients receiving What happens in patients receiving TAVI without CEP? TAVI with CEP? DISABLING STROKE DISABLING STROKE What are the NON-DISABLING STROKE What are the NON-DISABLING STROKE clinical outcomes? cli

  30. Slide 30: Economic Benefits of SENTINEL CPS

    Economic Benefits of SENTINEL CPS ~6,700 TAVI PATIENTS In the UK in 2021 What happens in patients receiving What happens in patients receiving TAVI without CEP? TAVI with CEP? What are the clinical outcomes? ~ 90 - 54 What is the DISABLING STROKES DISABLING STROKES AVOIDED What are economic impact?

  31. Slide 31: Why protect TAVI patients from Stroke?

    Why protect TAVI patients from Stroke? 1 Stroke is a severe and devastating event for the patient with a huge impact in terms of clinical outcomes and quality of life. 2 Stroke has a direct impact on healthcare systems resulting in high costs and is also considered a public health problem due to ser

Boston Scientific — Technical Presentation (2023) on 6ix